Contraceptive Devices Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Growth Factors of Contraceptive Devices Market

The global contraceptive devices market has experienced significant growth over the past few decades, driven by increased awareness of contraception, effective methods for preventing conception, and robust government initiatives promoting women's and child health. According ta report by Fortune Business Insights, the market was valued at USD 7,013.8 million in 2017 and is projected treach USD 16,648.3 million by 2032, exhibiting a compound annual growth rate (CAGR) of 5.9% during the forecast period.

Market Segmentation

Contraceptive devices are broadly categorized based on product type, technology, and distribution channels.

  • Product Type:
Male Contraceptive Devices

Female Contraceptive Devices: This segment includes vaginal rings, intrauterine devices (IUDs), sub-dermal implants, female condoms, diaphragms, and sponges. The availability and variety of female contraceptive devices, along with the significant uptake of IUDs globally, are propelling sales in this segment. Female contraceptive devices are expected tremain dominant throughout the forecast period.
  • Technology:
Hormonal Contraceptives: These are estimated tlead the market in terms of revenue between 2018 and 2025, attributable ttheir rising preference and efficiency.

Barrier Contraceptives
  • Distribution Channels:
Hospital Pharmacy: A major source for contraceptive devices, owing tthe increased uptake of implantable devices by healthcare professionals and active government support for distribution through government-aided hospitals.

Retail Pharmacy

Clinics

Online Channels

Public Channel & NGOs

Others

Regional Analysis

North America dominated the contraceptive devices market with a market share of 48.74% in 2017, accounting for USD 3,418.8 million. This dominance is attributable tthe upsurge in the usage of male condoms in the U.S. and Canada. However, the Asia Pacific region is anticipated texhibit the highest CAGR during the forecast period. Proactive governments in densely populated countries such as China and India are focusing on implementing population control measures, thereby augmenting the market in this region.

Key Market Drivers

1. Government Initiatives: Active participation by governments in promoting family planning and contraception, especially in emerging nations, is a key factor driving the global contraceptive devices market. Robust government promotions and schemes for women's and child health have significantly increased the use of contraceptive devices.

2. Awareness and Education: Improving literacy rates, especially among women, have encouraged the rapid adoption of contraceptive devices. Awareness of contraception and the presence of effective methods for preventing conception are major determinants of national pregnancy and birth rates.

3. Technological Advancements: The introduction of novel contraceptive devices, such as hormonal implants and advanced IUDs, has provided users with more options, thereby increasing adoption rates. For instance, in September 2016, Bayer AG received FDA approval for Kyleena, an intrauterine system for the intentional prevention of pregnancy for up tfive years, providing a new birth control option for women.

Challenges

Despite the positive growth trajectory, the contraceptive devices market faces certain challenges:
  • Side Effects: Some contraceptive devices, particularly hormonal ones, may have side effects such as nausea, headaches, and mood changes, which can deter usage.
  • Cultural and Religious Beliefs: In certain regions, cultural and religious beliefs may hinder the acceptance and use of contraceptive devices.
  • Access and Availability: In low-income and rural areas, access ta variety of contraceptive devices may be limited due teconomic constraints or lack of healthcare infrastructure.
Future Outlook

The contraceptive devices market is poised for substantial growth in the coming years. Factors such as increasing awareness, government initiatives, and technological advancements are expected tcontinue driving the market. Moreover, the focus on women's health and reproductive rights is likely tlead tmore supportive policies and funding, further propelling market growth.

In conclusion, the global contraceptive devices market is undergoing significant transformation, with a positive outlook for the future. Stakeholders, including manufacturers, healthcare providers, and governments, play crucial roles in addressing challenges and ensuring the availability and acceptance of contraceptive devices worldwide.

SEGMENTATION DETAILS

By Product Type
  • Male Contraceptive Devices
  • Female Contraceptive Devices
  • Female Condoms, Diaphragms & Sponges
  • Vaginal Rings
  • Intrauterine Devices
  • Sub-dermal Implants
  • Others
By Technology
  • Hormonal Contraceptives
  • Barrier Contraceptives
By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Clinics
  • Online Channels
  • Public Channel & NGO
  • Others
By Geography
  • North America (USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexicand Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)


Please Note: It will take 5-6 business days to complete the report upon order confirmation.


1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Fertility Statistics - Key Countries, 2017
4.2. New Product Launch
4.3. Key Industry Trends
4.4. Regulatory Scenario - Key Countries
4.5. Key Technological Advancements
4.6. Recent Industry Developments - Partnerships, Mergers & Acquisitions
5. Global Contraceptive Devices Market Analysis, Insights, and Forecast (2014-2025)
5.1. Key Findings/ Summary
5.2. Market Analysis, Insights, and Forecast – By Product Type
5.2.1. Male Contraceptive Devices
5.2.2. Female Contraceptive Devices
5.2.2.1. Female Condoms, Diaphragms & Sponges
5.2.2.2. Vaginal Rings
5.2.2.3. Intrauterine Devices
5.2.2.4. Sub-dermal Implants
5.2.2.5. Others
5.3. Market Analysis, Insights, and Forecast – By Technology
5.3.1. Hormonal Contraceptives
5.3.2. Barrier Contraceptives
5.4. Market Analysis, Insights, and Forecast – By Distribution Channel
5.4.1. Hospital Pharmacy
5.4.2. Retail Pharmacy
5.4.3. Clinics
5.4.4. Online Channel
5.4.5. Public Channel & NGOs
5.4.6. Others
5.5. Market Analysis, Insights, and Forecast – By Region
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Latin America
5.5.5. Middle East & Africa
6. North America Contraceptive Devices Market Analysis, Insights, and Forecast (2014-2025)
6.1. Key Findings/ Summary
6.2. Market Analysis, Insights, and Forecast – By Product Type
6.2.1. Male Contraceptive Devices
6.2.2. Female Contraceptive Devices
6.2.2.1. Female Condoms, Diaphragms & Sponges
6.2.2.2. Vaginal Rings
6.2.2.3. Intrauterine Devices
6.2.2.4. Sub-dermal Implants
6.2.2.5. Others
6.3. Market Analysis, Insights, and Forecast – By Technology
6.3.1. Hormonal Contraceptives
6.3.2. Barrier Contraceptives
6.4. Market Analysis, Insights, and Forecast – By Distribution Channel
6.4.1. Hospital Pharmacy
6.4.2. Retail Pharmacy
6.4.3. Clinics
6.4.4. Online Channel
6.4.5. Public Channel & NGOs
6.4.6. Others
6.5. Market Analysis, Insights, and Forecast – By Country
6.5.1. U.S.
6.5.2. Canada
7. Europe Contraceptive Devices Market Analysis, Insights, and Forecast (2014-2025)
7.1. Key Findings/ Summary
7.2. Market Analysis, Insights, and Forecast – By Product Type
7.2.1. Male Contraceptive Devices
7.2.2. Female Contraceptive Devices
7.2.2.1. Female Condoms, Diaphragms & Sponges
7.2.2.2. Vaginal Rings
7.2.2.3. Intrauterine Devices
7.2.2.4. Sub-dermal Implants
7.2.2.5. Others
7.3. Market Analysis, Insights, and Forecast – By Technology
7.3.1. Hormonal Contraceptives
7.3.2. Barrier Contraceptives
7.4. Market Analysis, Insights, and Forecast – By Distribution Channel
7.4.1. Hospital Pharmacy
7.4.2. Retail Pharmacy
7.4.3. Clinics
7.4.4. Online Channel
7.4.5. Public Channel & NGOs
7.4.6. Others
7.5. Market Analysis, Insights, and Forecast – By Country/Sub-region
7.5.1. U.K.
7.5.2. Germany
7.5.3. France
7.5.4. Italy
7.5.5. Spain
7.5.6. Scandinavia
7.5.7. Rest of Europe
(Similar structured sections for Asia Pacific, Latin America, and Middle East & Africa)
11. Competitive Analysis
11.1. Key Industry Developments
11.2. Global Market Share Analysis (2017)
11.3. Competition Dashboard
11.4. Comparative Analysis – Major Players
11.5. Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials)
11.5.1. Bayer AG
11.5.2. Pfizer Inc.
11.5.3. Janssen Global Services, LLC
11.5.4. Teva Pharmaceutical Industries Ltd.
11.5.5. Merck & Co., Inc.
11.5.6. Mylan N.V.
11.5.7. Allergan
11.5.8. Reckitt Benckiser Group plc
11.5.9. Veru Inc.
11.5.10. Church & Dwight Co., Inc.
11.5.11. Medisafe Distribution Inc.
11.5.12. Other Prominent Players
12. Strategic Recommendations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings